Approval · Notice of Compliance 18539 · 2016
CLEVIPREX: Notice of Compliance 18539
Issued September 29, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18539
- Date
- September 29, 2016
- Company
- Chiesi Farmaceutici S.P.A.Parma, --, Italy
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLEVIPREX | 02366223 | Marketed |
Medicinal ingredients
- CLEVIDIPINE 0.5 MG per ML